Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monoacylglycerol lipase inhibitor - Janssen Pharmaceutica

Next Previous
Drug Profile

Monoacylglycerol lipase inhibitor - Janssen Pharmaceutica

Alternative Names: Small molecule MGLLi

Latest Information Update: 22 Aug 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Janssen Pharmaceutica
  • Class Azabicyclo compounds; Behavioural disorder therapies; Small molecules
  • Mechanism of Action Monoacylglycerol lipase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Psychiatric disorders

Most Recent Events

  • 08 Aug 2022 Monoacylglycerol lipase inhibitor - Janssen Pharmaceutica is available for licensing as of 25 Jul 2022. https://www.janssen.com/belgium/collaboration
  • 25 Jul 2022 Phase-I clinical trials in Psychiatric disorders in Belgium (unspecified route) before July 2022 (Johnson and Johnson pipeline, July 2022)
  • 10 Feb 2021 Janssen has patent for MGL modulators in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top